IMU 9.26% 5.9¢ imugene limited

Ann: Imugene Appoints Dr John Byon as SVP Clinical Development, page-31

  1. 673 Posts.
    lightbulb Created with Sketch. 49
    Fate Therapeutics Inc... down 75% YTD ... He may fit in well unfortunately
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.